->

Mutsva adjuvant kurapwa kwekenza yepancreatic inobuda

Share This Post

Mubvunzurudzo ichangobva kuitika, Dr. Afsaneh Barzi, mutevedzeri wemupurofesa wemishonga yekiriniki paYunivhesiti yeSouthern California Norris Comprehensive Cancer Center, akakuudza nezvehutano huripo uye huri kubuda hutsva hwe adjuvant kuvarwere vane non-metastatic pancreatic cancer.

Gemcitabine inopihwa kuvarwere vane gomarara repancreatic seyakajairwa tsika kuongorora mhinduro. Nekudaro, Barzi akataura kuti mhinduro yemurwere kugemcitabine yaive yakaipa kwazvo uye kuti varwere vazhinji vakatadza kuvhiyiwa. Iyo LAPACT kuyedza yakaongorora iyo yekubatanidza kurapa kwegemcitabine uye nab-paclitaxel (Abraxane). Kuyedza kunoratidza kuti makumi matatu muzana muzana evarwara nekenza yepancreatic vanopindura kurapwa, uye vangangoita gumi muzana muzana vegomarara repancreatic cancer vanogona kurapwa kurapwa.

Pamusoro pezvo, ongororo yekuongorora yeFOLFIRINOX yevarwere vane cancer yepancreatic yakaratidza kuti vangangoita 28% yevarwere vepancreatic cancer vakakwanisa kuvhiyiwa. Barzi akatsanangura kuti sezvo chemotherapy inowedzera kushanda, mukana wekubvisa resection unowedzera. Nokudaro, kubviswa kwemurwere kunofanira kuongororwa zvakakodzera. Barzi akagumisa kuti kunyangwe varwere vazhinji vangangove vasina kukodzera kuvhiyiwa, zvichiri kukosha kuongorora varwere kuti vawane varwere vanogona kuvhiyiwa mushure mekurapa neoadjuvant.

https://www.onclive.com/conference-coverage/soss-gi-usc-2018/dr-barzi-on-available-and-emerging-neoadjuvant-approaches-in-pancreatic-cancer

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Alysha Mendossa April 29, 2024
Basa revaparamedics mukubudirira kweCAR T Cell therapy
CAR T-Cell kurapa

Basa revaparamedics mukubudirira kweCAR T Cell therapy

Paramedics inobata basa rakakosha mukubudirira kweCAR T-cell therapy nekuona kuchengetwa kwemurwere pasina musono panguva yese yekurapa. Vanopa rubatsiro rwakakosha panguva yekufambisa, kutarisa zviratidzo zvinokosha zvevarwere, uye kupa rubatsiro rwechimbichimbi kana matambudziko amuka. Kupindura kwavo nekukurumidza uye kutarisirwa kwehunyanzvi kunobatsira mukuchengetedzeka kwese uye kushanda kwekurapa, kufambisa shanduko yakapfava pakati pezvirongwa zvehutano uye kuvandudza mhedzisiro yevarwere munzvimbo yakaoma yemhando yepamusoro cellular therapies.

Susan Hau April 29, 2024

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Taura nesu
Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa